Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.35 |
| ▸ | DCK | P27707 | 9/20 | 0.33 |
| ▸ | CDK1 | P06493 | 1/20 | 0.31 |
| ▸ | CDK4 | P11802 | 1/20 | 0.31 |
| ▸ | CCND1 | P24385 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4585346 | 0.91 | ALB (0.37) | ALBDCKCDK1CDK4CCND1 | |
| SCHEMBL598982 | 0.87 | DCK (0.41) | ALBDCK | |
| SCHEMBL597971 | 0.85 | ALB (0.35) | ALBDCK | |
| SCHEMBL597543 | 0.82 | DCK (0.40) | ALBDCKCDK2 | |
| SCHEMBL597929 | 0.82 | DCK (0.40) | ALBDCK | |
| SCHEMBL598749 | 0.82 | ALB (0.38) | ALBDCK | |
| SCHEMBL598692 | 0.82 | DCK (0.42) | ALBDCK | |
| SCHEMBL598529 | 0.81 | ALB (0.36) | ALBDCK | |
| SCHEMBL598445 | 0.81 | DCK (0.38) | ALBDCK | |
| SCHEMBL597942 | 0.81 | ALB (0.35) | ALBDCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1569652-A4 | N SP 4 /SP-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS | PHARMASSET INC (US) | 2008-07-02 | — | — | EP | claimed |
| EP-1569652-A2 | N SP 4 /SP-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS | Pharmasset Ltd. (BB) | 2005-09-07 | — | — | EP | claimed |
| WO-2003063771-A2 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS | PHARMASSET LTD. (BB) | 2003-08-07 | — | — | WO | claimed |